Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Conditions
- PCV
- Polypoidal Choroidal Vasculopathy
Interventions
- DRUG: high-dose ranibizumab
- DRUG: ranibizumab
Sponsor
Hawaii Pacific Health
Collaborators